ArticleMolecular & cellular proteomics : MCP2018
Systematic Identification of Lysine 2-hydroxyisobutyrylated Proteins in
Open access · hybridAbstract read
In one paragraph
Article in Molecular & cellular proteomics : MCP, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 55 citations in OpenAlex.
- Global profiling of transcriptome, proteome and 2-hydroxyisobutyrylome in radioresistant lung adenocarcinoma cell.BMC genomics · 2024Article
- Substrate and Functional Diversity of Protein Lysine Post-translational Modifications.Genomics, proteomics & bioinformatics · 2024Review
- An Integrated Analytical Approach for Screening Functional Post-Translational Modification Sites in Metabolic Enzymes.ACS omega · 2024Article
- A glimpse into novel acylations and their emerging role in regulating cancer metastasis.Cellular and molecular life sciences : CMLS · 2024Review
- Proteomic analysis of lysine 2-hydroxyisobutyryl in SLE reveals protein modification alteration in complement and coagulation cascades and platelet activation Pathways.BMC medical genomics · 2023Article
- ResNetKhib: a novel cell type-specific tool for predicting lysine 2-hydroxyisobutylation sites via transfer learning.Briefings in bioinformatics · 2023Article
- Proteomic analysis of protein lysine 2-hydroxyisobutyrylation (KBMC plant biology · 2023Article
- Qualitative lysine crotonylation and 2-hydroxyisobutyrylation analysis in the ovarian tissue proteome of piglets.Frontiers in cell and developmental biology · 2023Article
- YiaC and CobB regulate lysine lactylation in Escherichia coli.Nature communications · 2022Article
- Proteome-wide analysis of lysine 2-hydroxyisobutyrylation in Frankliniella occidentalis.BMC genomics · 2022Article
- Global Profiling of 2-hydroxyisobutyrylome in Common Wheat.Genomics, proteomics & bioinformatics · 2022Article
- Quantitative multiplexed proteomics analysis reveals reshaping of the lysine 2-hydroxyisobutyrylome in Fusarium graminearum by tebuconazole.BMC genomics · 2022Article
- TmcA functions as a lysine 2-hydroxyisobutyryltransferase to regulate transcription.Nature chemical biology · 2022Article
- Global landscape of 2-hydroxyisobutyrylation in human pancreatic cancer.Frontiers in oncology · 2022Article
- Global analysis of protein lysine 2-hydroxyisobutyrylation (KBMC genomics · 2021Article
- Global analysis of lysine 2-hydroxyisobutyrylation in wheat root.Scientific reports · 2021Article
- Quantitative proteomics analysis of lysine 2-hydroxyisobutyrylation in IgA nephropathy.Clinical proteomics · 2021Article
- Article
- Proteome-Wide Analysis of Lysine 2-Hydroxyisobutyrylation inFrontiers in microbiology · 2021Article
- Systematic analysis of lysine 2-hydroxyisobutyrylation posttranslational modification in wheat leaves.PloS one · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 3 institutions in 3 countries.
Hanyang DongFrom the ‡2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
Zhenchang GuoFrom the ‡2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
Wei Feng¶School of Biomedical Engineering, Tianjin Medical University, Tianjin 300070, China.
Tao Zhang¶School of Biomedical Engineering, Tianjin Medical University, Tianjin 300070, China.
Guijin ZhaiFrom the ‡2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
Agata Palusiak‖Laboratory of General Microbiology, Department of Biology of Bacteria, Institute of Microbiology, Biotechnology and Immunology, University of Lodz, Lodz, Poland.
Antoni Rozalski‖Laboratory of General Microbiology, Department of Biology of Bacteria, Institute of Microbiology, Biotechnology and Immunology, University of Lodz, Lodz, Poland.
Shanshan TianFrom the ‡2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
Xue BaiFrom the ‡2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
Lijin ShenFrom the ‡2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
Pu ChenFrom the ‡2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.
Quan Wang§Department of Immunology, Key Laboratory of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Enguo Fan‡‡Institut für Biochemie und Molekularbiologie, Universität Freiburg, Stefan-Meier-Straβe 17, Freiburg 79104, Germany.
Zhongyi Cheng§§Jingjie PTM BioLab Co Ltd, Hangzhou Econ & Technol Dev Area, Hangzhou 310018, Zhejiang, China.
Kai ZhangFrom the ‡2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China; kzhang@tmu.edu.cn.
Tianjin Medical University · CNUniversity of Łódź · PLUniversity of Freiburg · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lysine 2-hydroxyisobutyrylation (K
Indexed as
Bacterial ProteinsLysinePhosphopyruvate HydrataseProtein Processing, Post-TranslationalProteus mirabilis2-hydroxyisobutyryl-lysineBacterial ProteinsLysinePhosphopyruvate Hydratase
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.